Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-25

Clinical Trial Update: The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring. [Phase 4]

View source ↗

Summary

This Phase 4 trial update analyzes the significance of deviations from the 12-hour serum clozapine monitoring schedule in patients with schizophrenia. The docum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

Sponsor: Anders Fink-Jensen, MD, DMSci | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED